Resource type: Biosimilars FDA Information

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
October 3, 2019 signalgroup
FDA Patient Materials
July 3, 2019 Katie Quinn
FDA Guidance: Additional Q&A Regarding Implementation of the BPCIA (2021)
July 3, 2019 Katie Quinn
FDA Guidance: Q&A Regarding Implementation of the BPCIA (2021)
July 3, 2019 Katie Quinn
FDA Draft Guidance: Reference Product Exclusivity
July 3, 2019 Katie Quinn
FDA Draft Guidance: Clinical Pharmacology Data Use
July 3, 2019 Katie Quinn
FDA Guidance: Quality Considerations for Demonstrating Biosimilarity
July 3, 2019 Katie Quinn
FDA Guidance: Scientific Considerations in Demonstrating Biosimilarity
July 3, 2019 Katie Quinn
Biosimilars: More Treatment Choices and Innovation
July 3, 2019 Katie Quinn
FDA Biosimilar Hub
July 3, 2019 Katie Quinn
Biologics Price Competition and Innovation Act of 2009